Clinical trials in follicular lymphoma

Trial Name

Description

Click for more information (external page)

GEN3013

Phase 1/2 study using antibody GEN3013 to target CD20- expressing cells in patients with B cell non-Hodgkin lymphoma

Suitable for patients with B cell non-Hodgkin lymphoma which has come back after previous treatment

BI 1206 CRUK CD32b

Phase 1/2a study looking at blocking the CD32b protein with the antibody BI 1206.

Suitable for patients with lymphoma which has come back after previous treatment

PARADIGME LYMRIT-37-01

A phase 2 trial comparing two different doses of Betalutin and lilotomab

Suitable for patients with lymphoma which has come back after previous treatment

PETReA

A phase 3 trial testing whether PET scans can help make treatment decisions for people with follicular lymhoma

Suitable for patients who haven't yet received any treatment

MEDI4736 (FUSION)

Phase 1-2 study to assess the safety and tolerability of durvalumab, the anti-pd-l1 antibody.

Suitable for patients with lymphoma which has come back after previous treatment

RiVa

Phase 2 trial testing the combination of rituximab and varlilumab in people with high grade and low grade lymphomas

Suitable for patients with lymphoma which has come back after previous treatment